Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
about
The PD-1 pathway in tolerance and autoimmunityThe anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patientsRole of the PD-1 pathway in the immune responseRisk factors and primary prevention trials for type 1 diabetesChronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cellsThe PD1:PD-L1/2 Pathway from Discovery to Clinical ImplementationThe Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in MelanomaThe role of the PD-1 pathway in autoimmunity and peripheral tolerancePD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice.PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responsesThe role of co-inhibitory signals in spontaneous tolerance of weakly mismatched transplantsInflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1.MSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis.Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus riskYin-Yang of costimulation: crucial controls of immune tolerance and function.PD-1, gender, and autoimmunity.Biochemical signaling of PD-1 on T cells and its functional implicationsDistinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background.Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.Alteration of intra-pancreatic target-organ specificity by abrogation of Aire in NOD mice.PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in miceRole of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cellsDendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway.B7-1 mediated costimulation regulates pancreatic autoimmunity.Regulation of T cell activation and tolerance by PDL2PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice.Blockade of the programmed death-1 (PD1) pathway undermines potent genetic protection from type 1 diabetes.The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivoIncreased autoimmune diabetes in pIgR-deficient NOD mice is due to a "Hitchhiking" interval that refines the genetic effect of Idd5.4.Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.PD-1 as an immune modulatory receptor.Association between PDCD1 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus in Three Main Ethnic Groups of the Malaysian Population.Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression.Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity.Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.The role of coinhibitory signaling pathways in transplantation and toleranceIL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells.Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus.Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.Tissue expression of PD-L1 mediates peripheral T cell tolerance.
P2860
Q24633549-4ADD0CF2-D9E9-4633-8C0C-2BAE161B12DBQ26797478-F8B0AE07-AEFA-440E-9570-82961D28CA06Q26828748-78409D20-B4AD-457F-97BE-EF3A0C4CFBB7Q27005625-62C42FA2-B488-4C47-82BD-480D3FE50AB3Q27304435-4EB61EA2-9BAA-47ED-94C3-B8407E065248Q28066941-770AFB80-9F33-4963-B39E-EDB4F9BF17C3Q28088496-311B6C26-8587-4844-BBF5-F3F6C306130AQ28304161-62164475-6B6A-4021-96AD-EBB403FFACA2Q30481410-771416BF-AE90-4299-ADD7-07F3847503E0Q30600094-38ABF444-4665-482F-BD59-C5824626C308Q33648838-855D27FC-82FD-40C2-B37B-799EC3875F9CQ33651093-C2C68A0A-3968-476C-822A-0AF47BD234E0Q33659353-08164A81-575F-4001-A38A-18B5D4BCBAA4Q33829687-E45D80B0-68FD-4A92-B0C9-BA7CE4F45759Q33872168-EF59AAA8-BB9B-48B7-AABD-5DBEF6FC7274Q33910421-82FC37BE-8B46-42F3-B302-E20938AB9F78Q34116796-79E278EB-227B-458C-A758-E5D9072C46ADQ34142507-103DF508-C9CF-47A7-86BF-8D72C4CA487FQ34173755-9E0AFE28-DEE7-4D82-B6C4-135778E981D7Q34546776-9C3E3878-850F-4234-9412-4C79D29F7CD5Q34577678-4ADE5BEB-C9EB-43DC-972E-1F5EF72858EDQ34578170-12227074-AF46-4E41-8FC9-530A27CDA00EQ34589567-F90ADC19-76F2-4A3E-AED5-88BA575A448CQ34763699-4F9B3C77-D9FA-4A2D-8DD4-654C9D718114Q34984502-2E8D7846-63B1-4A1F-8FD4-24A9DB437FCBQ35004384-1CA555CD-18F8-4967-A8AB-57C790F59778Q35107621-444FFB60-6707-485F-B364-B0BB735522D4Q35140721-44998283-B5C0-4084-B485-97DC732DAB74Q35249967-A5D8BA1F-D458-4A4D-9F68-F76B45585294Q35329213-D7F0FD7C-74E0-44D7-8E09-B884FFDC08C6Q35681585-1661B7BE-C838-4386-885F-10E540853A31Q35723027-D871C50C-A585-4E0C-AF27-D0949CDF0995Q35742964-36F5AF3F-0D3F-4ABD-88AA-01254F9190EFQ35870655-C8B0AC66-972D-4D5B-8937-86CE5031923EQ35901700-F817AB6B-022F-45B0-9FFD-6EED94C3B2C3Q35928357-6F487015-69D2-4E50-B81C-0E1AA057615FQ36140226-6A9772D2-E706-4579-B5DC-A93FD64C33C4Q36184263-95C209F9-BF21-4049-B11C-E62903499806Q36228158-53FA1032-853A-4FC6-8FCF-1C5F491804B7Q36228541-3EA895B6-AEC9-42EC-9BAD-4431C8D255AC
P2860
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
@ast
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
@en
type
label
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
@ast
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
@en
prefLabel
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
@ast
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
@en
P2093
P2860
P356
P1476
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
@en
P2093
Hiroshi Hiai
Taku Okazaki
Taku Yoshida
P2860
P304
11823-11828
P356
10.1073/PNAS.0505497102
P407
P577
2005-08-08T00:00:00Z